VR Adviser’s Korro Bio KRRO Stock Holding History

VR Adviser’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.4M	Buy	+1,009,500	New	+$11.1M	0.43%	30

Other funds holding KRRO

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VR Adviser's KRRO Position: Q1 2026 in Review

VR Adviser opened a new position in Korro Bio (KRRO) in Q1 2026: 1,009,500 shares worth $11.4M. The stake represents 0.43% of the portfolio and ranks #30 among its holdings.

99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

VR Adviser held 1,009,500 shares of Korro Bio worth $11.4M as of Q1 2026.
Korro Bio was a new VR Adviser position in Q1 2026.
Korro Bio made up 0.43% of VR Adviser's portfolio in Q1 2026, its #30 holding.
99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on VR Adviser's 13F filing for Q1 2026, filed 15 May 2026.